ArticleBreast cancer management
The role of radiotherapy-resistant stem cells in breast cancer recurrence.
Article in Breast cancer management. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Understanding the autophagic functions in cancer stem cell maintenance and therapy resistance.Expert reviews in molecular medicine · 2024Review
- A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer.Journal of advanced research · 2023Review
- Cancer stem cell characteristics and their potential as therapeutic targets.Medical oncology (Northwood, London, England) · 2021Review
- The beneficial role of SIRT1 activator on chemo- and radiosensitization of breast cancer cells in response to IL-6.Molecular biology reports · 2020Article
- CPT1A/2-Mediated FAO Enhancement-A Metabolic Target in Radioresistant Breast Cancer.Frontiers in oncology · 2019Article
- Rac1 is a potential target to circumvent radioresistance.Journal of thoracic disease · 2016Article
- The role of peroxiredoxin II in chemoresistance of breast cancer cells.Breast cancer (Dove Medical Press) · 2014Review
- Enhanced radiation response in radioresistant MCF-7 cells by targeting peroxiredoxin II.Breast cancer (Dove Medical Press) · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.